Young Infants, Children Born Prematurely Face Highest Risk for RSV Hospitalization: Daily Dose
Your daily dose of the clinical news you may have missed.
Tighter Glycemic Control in Type 2 Diabetes May Reduce Risk for All-Cause Dementia: New Findings
Comprehensive management of T2D in primary care settings reduced risk of all-cause dementia by 28%, with lower HbA1c linked to lower, but still elevated risk.
First-Ever MDMA-Assisted Therapy for PTSD is Granted FDA Priority Review
If the FDA approves the treatment, it will be the first-ever MDMA-assisted therapy and psychedelic-assisted therapy. The PDUFA date is set for August 11, 2024.
Preventive Health Screenings Continue to Lag Post-Pandemic: Daily Dose
Women with Poor Sleep During Midlife at Significantly Elevated Risk for Future CVD
Women aged 40 to 65 years who had persistent insomnia and poor sleep duration were at a 75% greater risk for incident CVD over 2 decades of follow up.
Reducing Out-of-Pocket Rx Costs May Help Improve Diabetes Outcomes, Particularly for those with Lower Incomes
Acute, preventable diabetes complications days fell by 8.4% among participants enrolled in a preventive drug list benefit and by even more among low-income subscribers.
SGLT2 Inhibitors Outperformed Other Oral Antidiabetic Drugs for Patients with T2D and NAFLD, According to New Research
Findings suggest that SGLT2 inhibitors may be the preferred choice for patients with both T2D and NAFLD, reported researchers.
Tirzepatide Linked to “Impressive” BP Reduction in Adults with Obesity: Daily Dose
Takeda Announces Approval of First Oral Therapy for Eosinophilic Esophagitis
Budesonide oral suspension is the first oral therapy for EoE and represents a needed option in the category, offering flexibility for both patients and clinicians.
Apixaban and Aspirin Appear Equal Against Recurrent Stroke in Individuals with Cardiopathy
Anticoagulation and antiplatelet therapy appeared equally effective in reducing risk of recurrent stroke following cryptogenic stroke in persons with evidence of atrial cardiopathy.
COVID-19 Hospitalization Linked to Higher Long-Term Mortality Risk Compared to Seasonal Influenza, Shows New Research
Hospitalization for COVID-19 was associated with higher long-term risks of death, adverse health outcomes, and significant cumulative excess DALYs vs influenza.
Altered Young Adult: Seen in the ED
Fever and confusion bring the young man in his twenties to the ED; roommates relate he's been weak and flu-like for 5 days. What's your diagnosis?
COPD Management & Pharmacotherapy: A GOLD Guideline Topline
Get GOLD Report updates at-a-glance on initiating pharmacotherapy, avoiding exacerbations, treating dyspnea, how to approach using ICS, plus other topics.
Cannabis Use and Risk of Prevalent Asthma: Daily Dose
13 Drugs Approved for Primary Care in 2023
Get a quick look at 13 of the many FDA-approved drugs in 2023 for conditions commonly seen in primary care.
GSK RSV Vaccine Arexvy Under FDA Priority Review for Prevention of RSV in High-Risk Adults Aged 50 to 59 Years
Approval of the application would extend the current Arexvy indication for prevention of RSV in adults aged 60 years and older; a June 2024 PDUFA date is set.
Depression, IBD Combo Raises Risk of Hospital Readmission, Mortality: Daily Dose
Novel Weight Loss Entrant from Amgen Challenges Duration of Effect and Dosing with Wegovy, Zepbound
Amgen's investigational maridebart cafraglutide in a phase 1 trial led to durable weight reduction following less frequent and lower doses, the company said.
Younger Infants and Children Born Prematurely at Highest Risk for RSV Hospitalization, According to New Study
Results showed nearly one-third of hospitalizations for acute respiratory illness among children aged <5 years were associated with RSV.
Risk for a Suicide Attempt Found 8-Fold Greater in Women with PCOS
Among women with PCOS, the risk for a suicide attempt was highest (by a factor of 9) among young adults aged 20 to 40 years, followed by adolescents.
